Delivery Order SPE2DB22D2007-SPE2DB25FJ4PV
- Not listed
- The Defense Logistics Agency awarded a $1,061.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Xyosted 75 mg/0.5 mL auto-injector pens. The contract, which is not set-aside and represents a non-competitive delivery order, will be completed by August 5, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,678.14 for Xyosted 75 mg/0.5 mL auto-injector supplies on August 4, 2025, with completion targeted for August 5, 2025. This firm fixed-price, non-set-aside delivery order will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency (DLA) awarded a $1,751.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector supplies on September 2, 2025, with completion targeted for September 3, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle active through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Xyosted 75 mg/0.5 ml auto-injector vials valued at $1,789.66. This is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Xyosted 75 mg/0.5 ml auto-injector prefilled syringes, valued at $1,207.05. This firm fixed-price delivery order represents a non-set-aside award and is scheduled for completion by June 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement serving military and veteran...
- The Defense Logistics Agency awarded a $1,270.28 firm fixed price delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector supplies, with an ultimate completion date of July 28, 2025. This non-set-aside contract represents a single delivery order fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,152.52 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector supplies, with an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 ml auto-injector supplies, valued at $1,006.78 under a firm fixed-price arrangement. The award, issued on June 30, 2025, with an ultimate completion date of July 1, 2025, represents a non-competitive delivery order. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,205.54 delivery order to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injectors on August 13, 2025, with completion targeted for August 14, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product delivered via auto-injection, representing part of the...
- The Defense Logistics Agency awarded a delivery order valued at $1,429.20 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 ml auto-injector units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 11, 2025, issued on September 10, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4PVDelivery Order
The Defense Logistics Agency has awarded a $1,233.05 delivery order to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector supply, with an ultimate completion date of September 4, 2025. This firm fixed price contract, awarded on September 3, 2025, represents a non-set-aside competitive award for pharmaceutical products to be delivered to the Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serving as a critical federal vendor for military and veteran healthcare systems. The company holds established delivery order relationships with the Defense Logistics Agency for a wide range of pharmaceutical products, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This specific award for testosterone replacement therapy medication demonstrates AmerisourceBergen's role in supplying essential pharmaceutical products to support Defense Health Agency and broader Department of Defense healthcare requirements through a flexible and competitive contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/3/25 |